Farallon Capital Management LLC Roivant Sciences Ltd. Transaction History
Farallon Capital Management LLC
- $19.9 Billion
- Q3 2024
A detailed history of Farallon Capital Management LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Farallon Capital Management LLC holds 37,000 shares of ROIV stock, worth $393,310. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37,000
Previous 673,000
94.5%
Holding current value
$393,310
Previous $7.11 Million
94.01%
% of portfolio
0.0%
Previous 0.03%
Shares
6 transactions
Others Institutions Holding ROIV
# of Institutions
312Shares Held
507MCall Options Held
1.26MPut Options Held
2.52M-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$701 Million6.27% of portfolio
-
Qvt Financial LP New York, NY65.8MShares$699 Million73.2% of portfolio
-
Viking Global Investors LP54.1MShares$575 Million2.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA41.7MShares$443 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$376 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.49B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...